Long-Term Disease Control With Second-Line Nivolumab Monotherapy in Malignant Pleural Mesothelioma: A Case Report
Cureus · 01.06.2026
DOI: 10.7759/cureus.110026 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 01.06.2026. Verfasst von Shohei Otsuka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, National Hospital Organization (NHO) Hakodate Medical Center, Hakodate, JPN. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, National Hospital Organization (NHO) Hakodate Medical Center, Hakodate, JPN.
Zitieren
APA
Otsuka, S., Hiraoka, K., & Iwashiro, N. (2026). Long-Term Disease Control With Second-Line Nivolumab Monotherapy in Malignant Pleural Mesothelioma: A Case Report. Cureus. https://doi.org/10.7759/cureus.110026
Vancouver
Otsuka S, Hiraoka K, Iwashiro N. Long-Term Disease Control With Second-Line Nivolumab Monotherapy in Malignant Pleural Mesothelioma: A Case Report. Cureus. 2026. doi:10.7759/cureus.110026
BibTeX
@article{Otsuka2026,
author = {Otsuka, Shohei and Hiraoka, Kei and Iwashiro, Nozomu},
title = {Long-Term Disease Control With Second-Line Nivolumab Monotherapy in Malignant Pleural Mesothelioma: A Case Report},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.110026}
}
EUVIMED